Carroll “Bo” Allen has over 40 years experience in multiple leadership positions within the pharmaceutical industry including 20 years in major pharmaceutical companies (Boehringer Ingelheim, Ciba Geigy, Sandoz, and Novartis). He has executive experience in various start-up biopharmaceutical companies including CoCensys, Kimeragen, and IgX. He founded Asklepion Biopharmaceuticals and Versalion Pharmaceuticals. He has extensive experience in the United States and global orphan drug markets and regulations as well as the implementation of orphan drug strategies.
Current role
SVP of Regulatory Affairs at Tenax Therapeutics
SVP of Regulatory Affairs at Mersana Therapeutics
SVP of Regulatory Affairs at Erasca
SVP of Regulatory Affairs & Quality Assurance at Sparrow Pharmaceuticals
SVP of Regulatory Affairs & Quality Assurance at Oakmont Senior Living